Evaluation of contribution of high frequency chest wall oscillation treatment to medical treatment in patients with acute exacerbations of COPD Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population Source: Eur Respir J 2014; 44: 1363-1366 Year: 2014
Lower muscle mass is related to poorer clinical outcomes in moderate to severe asthma Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Baseline anxiety independently predicts functional limitation and reduced health status in severe emphysema Source: Annual Congress 2006 - Quality of life in various respiratory diseases Year: 2006
Comparison of functionality and symptoms in COPD patients with different nutritional status Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016
Assessment of the dependence between nutritional status and functional damage of lungs in COPD patients Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Reduced grip strength is related to frequency of exacerbations and lower health status in COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Combination of chest wall mobilization and respiratory muscle training in comprehensive pulmonary rehabilitation improves pulmonary function in patients with stable COPD Source: Annual Congress 2008 - Technologies and techniques in rehabilitation Year: 2008
A high degree of dyspnea is associated with poor exercise capacity in COPD patients, airflow obstruction being equal Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018
The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014
Impact of standardised chest physiotherapy with high frequency chest wall oscillation on lung clearance index in sputum producing patients with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
High frequency chest wall oscillation system compared with manual chest wall physiotherapy for managing airway clearance in patients with complex neurological disorders: A UK-based cost-effectiveness analysis Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019
Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality Source: Eur Respir J 2006; 28: Suppl. 50, 66s Year: 2006
The effect of endoscopic lung volume reduction on functional outcomes in patients with severe emphysema. Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients Year: 2019
Role of diaphragm dysfunction and nutritional status on dyspnea pathogenesis in patients with COPD. Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020
Effect of airway bacterial load and microbial patterns on dyspnea, exercise performance and health status in patients with stable COPD Source: Eur Respir J 2006; 28: Suppl. 50, 809s Year: 2006
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients Source: Annual Congress 2013 –COPD treatment Year: 2013
Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020
Peripheral muscle function in patients with COPD and restrictive chest wall disease Source: Eur Respir J 2005; 26: Suppl. 49, 108s Year: 2005
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011